Polaryx Therapeutics, Inc. Common Stock (PLYX) — Net Asset Quality Index
Polaryx Therapeutics, Inc. Common Stock (PLYX) has a Net Asset Quality Index of 92.6% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $11.81 Million minus total liabilities of $873.00K yields net assets of $10.94 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Polaryx Therapeutics, Inc. Common Stock (PLYX) total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Polaryx Therapeutics, Inc. Common Stock Net Asset Quality Index Over Time (2023–2025)
This chart shows how Polaryx Therapeutics, Inc. Common Stock's Net Asset Quality Index has evolved across 3 annual periods from 2023 to 2025. As of June 2026, the index stands at 92.6%, representing net assets of $10.94 Million against total assets of $11.81 Million USD. For live market cap and overall valuation, see PLYX market cap overview.
Annual Net Asset Quality Index for Polaryx Therapeutics, Inc. Common Stock (2023–2025)
The table below presents the year-by-year Net Asset Quality Index for Polaryx Therapeutics, Inc. Common Stock from 2023 to 2025, covering 3 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See net assets of Polaryx Therapeutics, Inc. Common Stock for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 84.2% | $4.57 Million | $5.42 Million | $855.00K | ▼ -10.0 pp |
| 2024 | 94.2% | $4.71 Million | $5.00 Million | $289.00K | ▲ +39.1 pp |
| 2023 | 55.2% | $1.28 Million | $2.31 Million | $1.04 Million | — |